1. Home
  2. FND vs CORT Comparison

FND vs CORT Comparison

Compare FND & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

N/A

Current Price

$45.91

Market Cap

4.9B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$114.53

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FND
CORT
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
9.7B
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
FND
CORT
Price
$45.91
$114.53
Analyst Decision
Hold
Buy
Analyst Count
23
5
Target Price
$58.59
★ $141.00
AVG Volume (30 Days)
★ 2.2M
815.6K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1.05
N/A
EPS
★ 1.25
0.09
Revenue
★ $4,684,088,000.00
$761,407,000.00
Revenue This Year
$3.63
$50.53
Revenue Next Year
$5.17
$48.75
P/E Ratio
★ $38.03
$1,275.83
Revenue Growth
5.12
★ 12.79
52 Week Low
$42.64
$28.66
52 Week High
$77.46
$126.38

Technical Indicators

Market Signals
Indicator
FND
CORT
Relative Strength Index (RSI) 35.86 51.85
Support Level $42.64 $108.33
Resistance Level $53.19 $124.30
Average True Range (ATR) 1.66 5.17
MACD 0.12 -0.14
Stochastic Oscillator 1.75 53.19

Price Performance

Historical Comparison
FND
CORT

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: